Health
Immunosuppressive therapies may be linked to severe COVID-19 in those with multiple sclerosis – News-Medical.Net
A new study examines the associations between immunosuppressive disease-modifying therapies (DMTs) used in MS with adverse outcomes in an international cohort of…
In the ongoing coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), patients with coexisting medical conditions have been noted to be at a higher risk of progressive and severe disease. Patients with multiple sclerosis (MS), who are often on immunosuppressive therapy, may be among these high-risk groups.
A new study, released on the medRxiv* preprint server, examines the associations between immunosuppressive disease-modifying…
-
Noosa News18 hours agoMeet Chad Burgess, Pauline Hanson’s One Nation Party
-
Noosa News19 hours agoWestern Queensland graziers begin grim stock count after catastrophic floods
-
Noosa News21 hours agoFrom Dreamy Dining Rooms to Moody Basement Bars, Nearly 200 Venues Have Been Shortlisted for the 2025 Australian Interior Design Awards
-
General17 hours agoTruck driver charged with causing death by dangerous driving after highway crash